tags

United States
US FDA Approves Bemotrizinol as New Sunscreen Active Ingredient

In a landmark move for the U.S. sunscreen industry, the FDA has approved Bemotrizinol (Bis-ethylhexyloxyphenol methoxyphenyl triazine) for inclusion in the over-the-counter (OTC) sunscreen monograph as a permitted active ingredient. Announced on June 9, 2026, this is the first new active ingredient added to the monograph in more than two decades, reflecting ongoing efforts to modernize the U.S. sunscreen regulatory system. The final order takes effect on August 9, 2026.